Designed for trade association, exhibitors, academic institutions and speakers, List and promote your online events
Largest database of verified shows since 2015, Detailed profiles of verified trade shows, conferences and consumer shows. Create your event and attract attendees and exhibitiors, Listing tools for verification, institution and corporation.
Connect with verified event organizers, Listing and RFP tools for verified venue operators.Size events by verified attendee and exhibitor count database
Research verified b2b events by industry and profession, Review virtual exhibitor showcase. Create Profile. Connect with verified event organizers and exhibitors.
Search 900k verified exhibitor database organizedby 2,000+ events since 2018.
Integrated management of all aspects of cardiometabolic risk is the only way to approach the rapidly growing epidemic of cardiovascular and metabolic disease. The Cardiometabolic Health Congress provides a one-of-a-kind opportunity to stay informed on the latest scientific and clinical developments in these overlapping disease areas through a comprehensive and integrated agenda.
The CMHC has grown to be the largest multidisciplinary conference addressing the prevention, diagnosis, and management of cardiometabolic diseases in the US.
CMHC offers new educational formats, 27+ credit hours, symposia and workshops, lively debates with ample time for Q&A, renowned faculty and Meet-the-Expert sessions, and an expanded exhibit hall showcasing technological innovations, products, and prevention tools to improve your practice.
Whether you're new to CMHC, or one of the many clinicians who has joined us in past years, please Register Today.
An exhibit booth is an investment as well as an engagement-and one that should begin reaping rewards the moment you submit your application. CMHC offers opportunities to engage with hundreds of leading clinicians and thought leaders before, during and after the Congress through our multimedia channels.
Who Should Exhibit?
Any company that wants to reach motivated, frontline clinicians involved in cardiometabolic risk management. CMHC attendees are diverse and multidisciplinary, yet they all share the desire for knowledge about the most useful products and services to improve patient outcomes.
Benefits & Enhanced Exposure in 2017!
Extensive promotion of exhibiting companies through multiple channels including CMHC program brochure mailings, email and social media campaigns, a listing and description in the conference guide, hyperlinks on the CMHC website and the CMHC App.
Individualized marketing support, with optional promotional opportunities to drive attendees to your booth!
Meet the Faculty Lounge in Exhibit Hall - Attendee Favorite!
Source : Event Website
Chair, Department of Cellular & Molecular Medicine, Vice Chair, Translational Research, Lerner Research Institute Section Head, Preventive Cardiology & Rehabilitation Director, Center for Cardiovascular Diagnostics & Prevention Cleveland Clinic Cleveland, OH
Stanley Hazen, MD, PhD, is the Head of the Section for Preventive Cardiology and Rehabilitation, Vice Chair of Translational Research, Lerner Research Institute, Director for the Center for Cardiovascular Diagnostics and Prevention, Director of the Cleveland Clinic Mass Spectrometry Core Facilities, Department Chair in the Department of Cell Biology and Section Head in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic.
Dr. Hazen is board-certified as a Diplomat of the American Board of Internal Medicine. He has also completed subspecialty training in endocrinology, diabetes and metabolism. He sees patients within the Preventive Cardiology Clinic, specializing in preventive cardiovascular medicine care of patients including treatment of hyperlipidemia, diabetes, hypertension, obesity. He also sees patients within the Cardiovascular Rehabilitation program. His research interests include understanding the role of inflammation and oxidant stress in the pathogenesis of atherosclerosis and other inflammatory diseases. He is an expert in mechanisms of atherosclerosis, HDL structure and metabolism, the biochemistry of leukocyte peroxidases, free radicals and reactive oxygen species and mechanisms of oxidative damage.
Dr. Hazen has published over 200 peer-reviewed articles, invited reviews and book chapters in the fields of atherosclerosis, oxidation and inflammation chemistry, and cardiovascular disease. He has received many honors and awards for his research work, which has contributed to new understandings of inflammation in cardiovascular disease and the development of new diagnostic and treatment tools. He is listed as a co-inventor on multiple patents for his work in identifying patients at increased risk for cardiovascular disease, diagnosing asthma, and treating inflammation and associated complications. He has been principal investigator on numerous National Institutes of Health grants and research awards related to his specialty interests.
He serves as reviewer for more than 20 scientific journals including Circulation, Analytical Biochemistry, Journal of Clinical Investigation, Journal of Biological Chemistry and the Journal of Lipid Research. Dr. Hazen is Associate Editor of the Journal of Lipid Research, and serves on the editorial board of Circulation, The Journal of Biological Chemistry and Free Radicals in Biology & Medicine. He has been invited to lecture at national and international symposia and conferences in both basic science and clinical fields alike, as well as workshops held by the National Academy of Science, and National Heart, Lung and Blood Institutes (National Institutes of Health) on Emerging Science for Environmental Health Decisions, mechanisms of atherogenesis, pulmonary immunobiology and inflammation, the origins of asthma, and nitric oxide biology.
Dr. Hazen has received numerous awards including election to membership in honorary societies in science and clinical arenas alike including the American Society for Clinical Investigation (ASCI) and the American Association of Physicians (AAP). He also is an elected fellow of the American Association for the Advancement of Science (AAAS). He holds memberships to the American College of Physicians, the American Federation for Medical Research, the American Heart Association Scientific Council for Arteriosclerosis, the American Medical Association, the American Society for Mass Spectrometry, the International Society for Free Radical Research, the Society for Free Radical Biology & Medicine, and the American Society for Investigative Pathology.
|Cardiometabolic Health Congress West 2021||Scottsdale||Arizona||-||-||Apr 16, 2021|
|Cardiometabolic Health Congress West 2020||Phoenix||Arizona||
|May 03, 2020|
|Cardiometabolic Health Congress West 2019||Phoenix||Arizona||
|May 03, 2019|
|13th Annual Cardiometabolic Health Congress (CMHC)||Boston||Massachusetts||
|Oct 24, 2018|
|12th Annual Cardiometabolic Health Congress (CMHC)||Boston||Massachusetts||-||
|Oct 04, 2017|
|11th Annual Cardiometabolic Health Congress (CMHC)||Boston||Massachusetts||-||-||Oct 05, 2016|
|2015 Cardiometabolic Health Congress (CMHC)||Boston||Massachusetts||-||-||Oct 21, 2015|
|2014 Cardiometabolic Health Congress (CMHC)||Boston||Massachusetts||-||-||Oct 22, 2014|
|ASE Echo Hawaii 2021 - American Society of Echocardiography||Waimea||Hawaii||
|-||Jan 18, 2021|
|2021 Mayo Clinic Hawaii Echo with Multimodality Imaging - Cardiovascular Medicine CME||Wailea||Hawaii||-||-||Jan 24, 2021|
|Mayo Clinic Arrhythmias and the Heart: A Cardiovascular Update 2020||Waimea||Hawaii||
|-||Feb 01, 2021|
|Tremblant Interventional Cardiology Meeting - TIC 2021||Montreal||Quebec||-||-||Feb 03, 2021|
|Valve Disease, Structural Interventions, and Diastology Summit 2021||-||-||Feb 05, 2021|